Eddie Sullivan, PHD

President and CEO, SAB Biotherapeutics

Eddie Sullivan, PHD

President and CEO, SAB Biotherapeutics

Biography

Eddie Sullivan, PhD, SAb Biotherapeutics

Dr. Sullivan is the president and CEO of Sab Biotherapeutics, a company that produced the world’s first large animals species that produces fully human polyclonal antibodies. He has been a thought leader in this field and worked with various committees and discussion groups that have focused on animal biotechnology and has actively participated in discussions for establishing a regulatory framework for genetically engineering animals.

Topic: The Use of Genetically Engineered Large Animals to Rapidly Respond to Emerging Infectious Disease Through the Production of Therapeutic Antibodies